http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-781551-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
filingDate 1956-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1957-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-781551-A
titleOfInvention N-carboxy-3,5-pyrazolidine-dione derivatives
abstract The invention comprises N-carboxy-3:5-pyrazolidinedione derivatives of the formul : <FORM:0781551/IV (a)/1> and <FORM:0781551/IV (a)/2> (wherein R1 represents phenyl, o -chlorohexyl, cyclohexyl or 4-ethoxyphenyl, R2 and R3 hydrogen, n-butyl or phenyl, and R4 an ethoxy or anilino radical), and their alkali metal salts, and a process for the preparation of amide derivatives of N-carboxy- and N-carbothionyl-3:5-pyrazolidinediones by reacting malonic acid halides and C-substituted malonic acid halides with semi-carbazides and thiosemicarbazides, or otherwise according to the following examples: (1) 1-phenyl-2-anilino-carbonyl - 3:5 - pyrazolidinedione is prepared by stirring malonic acid dichloride with 1:4-diphenylsemicarbazide in benzene, or by heating 1-phenyl-3:5-pyrazolidinedione with phenyl isocyanate; (2) 1 - phenyl - 2 - anilinocarbonyl-4 - n - butyl - 3:5 - pyrazolidinedione is analogously produced from the corresponding n-butyl-substituted starting materials; (3) 1-phenyl - 3:5 - pyrazolidinedione is heated with o -chlorohexyl isocyanate to form 1-phenyl - 2 - o - chlorohexylaminocarbonyl-3:5 - pyrazolidinedione; (4) cyclohexyl isocyanate similarly yields 1-phenyl-2-cyclohexylaminocarbonyl - 3:5 - pyrazolidinedione; (5) 4-ethoxyphenyl isocyanate similarly yields 1-phenyl - 2 - (4 - ethoxyanilinocarbonyl) - 3:5-pyrazolidinedione; (6) 1-ethoxycarbonyl-4-phenyl - 3:5 - pyrazolidinedione is heated with phenyl isocyanate to give 1-ethoxycarbonyl-2-anilinocarbonyl - 4 - phenyl - 3:5 - pyrazolidinedione; (7) 4 - phenyl - 3:5 - pyrazolidinedione similarly yields 1:2 - bis - anilinocarbonyl - 4-phenyl - 3:5 - pyrazolidinedione; (8) 1:4 - diphenyl - 3:5 - pyrazolidinedione similarly yields 1:4 - diphenyl - 2 - anilinocarbonyl - 3:5-pyrazolidinedione; (9) malonic acid dichloride is stirred with 1-phenyl-4:4-dimethylsemicarbazide in benzene to produce 1-phenyl-2 - dimethylaminocarbonyl - 3:5 - pyrazolidinedione; (10) C-phenylmalonic acid dichloride similarly yields 1:4-diphenyl-2-dimethylaminocarbonyl - 3:5 - pyrazolidinedione, also obtained by carrying out the reaction in the presence of dimethylaniline, or from C-phenylmalonic acid in the presence of PCl3; (11) C-n-butylmalonic acid dichloride is reacted as in (9) to form 1 - phenyl - 2 - dimethylaminocarbonyl-4 - n - butyl - 3:5 - pyrazolidinedione; (12) malonic acid dichloride is stirred with 1:4-diphenylthiosemicarbazide in benzene to give 1-phenyl - 2 - anilinothiocarbonyl - 3:5 - pyrazolidinedione; (13) 1 - phenyl - 3:5 - pyrazolidinedione is heated with dimethylcarbamic acid chloride to produce 1-phenyl-2-dimethylaminocarbonyl - 3 - (N:N - dimethylcarbamoyloxy) - 2:5 - dihydropyrazolone - 5. Additional starting materials specified are b -ethoxyethylmalonic acid dichloride; 1-phenyl-4-a -pyridyl- and 1:4:4-triphenyl-semicarbazide. The products are useful as analgesics. Starting materials. 1-Phenyl-4-n-butyl-3:5-pyrazolidinedione is prepared by reacting C-n-butylmalonic acid dimethyl ester with phenylhydrazine in ethanolic sodium ethoxide solution. 1-Ethoxycarbonyl-4-phenyl-3:5-pyrazolidinedione is prepared by reacting 1-ethoxycarbonylhydrazine with phenylmalonic acid dichloride in ether. 4-Phenyl-3:5-pyrazolidinedione is prepared from C-phenylmalonic acid and hydrazine hydrate in ethanolic sodium ethoxide solution.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3379533-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3124591-A
priorityDate 1955-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449682174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412617767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449662972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414269513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131885302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420301844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12294915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421069250
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457582651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414017954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415822775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415753224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431998195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723922

Total number of triples: 52.